Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Breast Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01140282
What this trial is testing

Exercise Program for Early Breast Cancer Survivors

Who this might be right for
Stage I Breast CancerStage II Breast CancerStage IIIA Breast Cancer+2 more
University of Southern California 106
Large-scale testing (Phase 3)UnknownNCT00002851
What this trial is testing

Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 4,000
Large-scale testing (Phase 3)Study completedNCT00127205
What this trial is testing

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 6,097
Not applicableStudy completedNCT03061175
What this trial is testing

Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy

Who this might be right for
Stage 0 Breast CancerStage I Breast CancerStage IA Breast Cancer+5 more
Rutgers, The State University of New Jersey 94
Not applicableEnded earlyNCT05243056
What this trial is testing

A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
University of Alabama at Birmingham 37
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07721259
What this trial is testing

A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
University of Washington 60
Not applicableStudy completedNCT00005957
What this trial is testing

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 1,832
Testing effectiveness (Phase 2)Ended earlyNCT00499681
What this trial is testing

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02150525
What this trial is testing

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Who this might be right for
Ductal Breast Carcinoma in SituBreast Cancer, Stage IBreast Cancer, Stage II+1 more
Ohio State University Comprehensive Cancer Center 52
Not applicableStudy completedNCT06106282
What this trial is testing

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
Mayo Clinic 105
Early research (Phase 1)Active Not RecruitingNCT05311397
What this trial is testing

A166 in Patients With Advanced Solid Malignant Tumors

Who this might be right for
Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT06806930
What this trial is testing

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+1 more
George Washington University 90
Early research (Phase 1)WithdrawnNCT01320787
What this trial is testing

18-F-Fluoroacetate as PET Imaging Agent

Who this might be right for
Brain CancerBreast CancerProstate Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00334542
What this trial is testing

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Early research (Phase 1)Study completedNCT04483505
What this trial is testing

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

Who this might be right for
Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast
Fundacion CRIS de Investigación para Vencer el Cáncer 9
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Testing effectiveness (Phase 2)Study completedNCT02689427
What this trial is testing

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 24
Next Page